A tick perched on the tip of a dew-covered green leaf in a forest
Lyme Disease: Pathophysiology, Staging, Diagnostic Testing, and Treatment Protocols

Lyme disease (Lyme borreliosis) is a systemic, tick-borne infection caused primarily by the spirochete Borrelia burgdorferi (and less commonly Borrelia mayonii in North America). As the most common vector-borne illness in the United States, its clinical manifestations evolve through distinct stages affecting the skin, nervous system, heart, and musculoskeletal joints.

Core Vector Transmission & Post-Exposure Prophylaxis

  • Primary Vector: Transmitted via the bite of infected Ixodes species ticks (Ixodes scapularis in the Northeast/Upper Midwest; Ixodes pacificus on the West Coast).
  • Transmission Window: Bacterial transmission requires an infected tick to remain attached and feed for at least 24 to 36 hours (typically >36–48 hours). Unengorged ticks removed within 24 hours carry negligible risk.
  • Post-Exposure Prophylaxis (PEP) Criteria: A single oral dose of Doxycycline 200 mg (in adults or children of any age) effectively prevents disease if ALL of the following criteria are met:
    1. Attached tick is identified as an Ixodes species and is engorged (attached ≥36 hours).
    2. Prophylaxis can be started within 72 hours of tick removal.
    3. Exposure occurred in a highly endemic area (≥20% local tick infection rate).
    4. Doxycycline is not contraindicated (e.g., severe allergy).

1. Clinical Presentation by Staging

Clinical Stage Characteristic Features & Organ Systems Key Clinical Pearls & Red Flags
Stage 1: Early Localized
(Days to Weeks post-bite)
Erythema Migrans (EM): Expandable annular rash expanding over days to ≥5 cm, often exhibiting a “bulls-eye” central clearing.
• Non-pruritic, non-painful.
• Flu-like symptoms (fatigue, fever, chills, myalgias, arthralgias, headache).
• Clinical diagnosis alone is sufficient; serology is frequently falsely negative at this stage.
• Un-treated EM self-resolves within 3–4 weeks, but infection progresses to late stages.
Stage 2: Early Disseminated
(Weeks to Months post-bite)
Neurologic: Unilateral or bilateral Cranial Nerve VII Palsy (Bell’s Palsy), lymphocytic aseptic meningitis, painful radiculoneuritis.
Cardiac: Lyme Carditis (variable AV heart block, myopericarditis).
Dermatologic: Multiple secondary EM skin lesions.
Bilateral Bell’s Palsy is highly pathognomonic for Lyme disease.
• Symptomatic AV block requires inpatient monitoring and IV antibiotic therapy.
Stage 3: Late Persistent
(Months to Years post-bite)
Musculoskeletal: Oligoarticular inflammatory arthritis affecting large joints (knee is classic) with marked effusion.
Neurologic: Lyme encephalopathy (subtle memory/cognitive decline), peripheral neuropathy, fatigue.
• Joint fluid aspiration reveals inflammatory synovial fluid (~25,000–50,000 WBCs/mcL).
• Can cause permanent structural joint damage if left untreated.

2. Diagnostic Approach & Serological Kinetics

Testing Phase Methodology Serological Kinetics & Interpretation
Step 1: Screening Assay Enzyme-Linked Immunosorbent Assay (ELISA) or Immunofluorescence Assay (IFA) High sensitivity. If negative, no further testing is needed (unless patient is in early Stage 1, where clinical diagnosis suffices). If positive or equivocal, proceed to Step 2.
Step 2: Confirmatory Assay Western Blot (IgM and IgG) OR Second Immunoassay (Modified Two-Tiered Testing) Symptoms <30 days: Interpret both IgM and IgG Western Blot.
Symptoms >30 days: Interpret IgG Western Blot ONLY (IgM alone yields high false-positive rates after 1 month).
Antibody Kinetics IgM & IgG Temporal Windows IgM: Peaks at 2–4 weeks post-onset; declines within 4–6 months.
IgG: Peaks at 6–8 weeks; may persist indefinitely (years) at low levels despite effective cure (does NOT signify active infection).

Diagnostic Pitfalls & Pearls

  • Do NOT Test Early Localized Lyme: Serologic testing during the first 2–3 weeks of infection has a high false-negative rate (>50%). Patients presenting with classic Erythema Migrans should be diagnosed and treated empirically without lab testing.
  • Routine Lab Non-Utility: Complete Blood Count (CBC) and routine chemistry panels are usually unremarkable and non-diagnostic.
  • IgG Persistence: Seropositivity (IgG) alone after successful treatment does not indicate active infection or treatment failure. Test of cure is not recommended.

3. Treatment Protocols by Clinical Manifestation

Clinical Manifestation First-Line Antibiotic Regimens Duration & Practice Considerations
Post-Exposure Prophylaxis Doxycycline: Single oral dose of 200 mg. Must be given within 72 hours of removing an engorged tick attached ≥36 hours in an endemic zone. Observation is appropriate if criteria are not met.
Early Localized (EM) & Mild Disseminated Doxycycline: 100 mg BID
Amoxicillin: 500 mg TID
Cefuroxime axetil: 500 mg BID
14-day duration (range 10–14 days). Doxycycline is preferred due to co-coverage for Anaplasma phagocytophilum. Amoxicillin or Cefuroxime preferred in pregnant/lactating patients.
Isolated Facial Palsy (CN VII) Oral Doxycycline: 100 mg BID 14 to 21-day duration. Corticosteroids are generally avoided unless severe facial paralysis occurs, in which case short-course steroids may be combined with antibiotics.
Lyme Carditis / Meningitis / Severe Neurologic IV Ceftriaxone: 2 g IV daily
(Alt: IV Cefotaxime or High-dose Oral Doxycycline if stable)
14 to 21-day duration. Inpatients with symptomatic AV heart block (1st degree with PR >300 ms, 2nd, or 3rd-degree block) require continuous telemetry until block resolves.
Lyme Arthritis (Stage 3) Oral Doxycycline, Amoxicillin, or Cefuroxime 28-day duration. If arthritis persists after a single 28-day oral course, a second 28-day oral course or a 14-day course of IV Ceftriaxone is indicated.

High-Yield Exam & Practice Pearls

  • Tick Attachment Window: An attached tick must feed for ≥24–36 hours to transmit Borrelia burgdorferi.
  • PEP Doxycycline Safety in Pediatrics: Short-course doxycycline (up to 21 days) is safe for children of all ages without risking tooth discoloration.
  • CN VII Palsy Differential: Bilateral facial nerve palsy is classic for Lyme disease (other causes: Sarcoidosis, Guillain-Barré Syndrome, HIV).
  • Early Stage Clinical Diagnosis: Erythema Migrans = Immediate treatment. Do NOT order serology for early localized disease.
  • Two-Tiered Rule: Never order a Western Blot without a preceding positive/equivocal ELISA screen. IgM Western Blot is only valid if symptoms are present for <30 days.
  • Prevention Essentials: Standard tick protection includes permethrin-treated clothing, DEET insect repellent, daily body checks, and immediate prompt tick removal using fine-tipped tweezers by pulling straight up.

Board Exam Recall: Pathogen = Borrelia burgdorferi | Vector = Ixodes scapularis / pacificus | Attachment time required = >24–36 hours | PEP = Doxycycline 200 mg single dose within 72 hrs | Stage 1 = Erythema Migrans (clinical dx) | Pathognomonic Stage 2 = Bilateral Bell’s palsy / AV heart block | Stage 3 = Oligoarticular knee arthritis | Diagnostic algorithm = Two-tiered (ELISA then Western Blot) | First-line oral tx = Doxycycline 14 days | Severe carditis/meningitis tx = IV Ceftriaxone. Prepared strictly for healthcare educational purposes.

Published on
August 31, 2026
|
Last Reviewed on
September 17, 2026
Connecting You and Primary Care
© 2026 TME HEALTHCARE. All rights reserved.